Nimomeg 10mg Infusion
Marketer
Ridhima Biocare
Salt Composition
Nimodipine (10mg)
Overview Nimomeg 10mg Infusion
Nimodipine 10mg intravenous infusion treats and protects against further brain damage following a subarachnoid hemorrhage (brain bleed). This calcium channel blocker enhances cerebral blood flow, mitigating detrimental neurological changes. Administration is strictly under physician oversight, with dosage tailored to the indication and condition severity. Continue the infusion as directed. Adhere meticulously to your physician's instructions. Common side effects encompass skin rash, headache, gastrointestinal upset, hypotension, and bradycardia. Report any persistent, worsening, or bothersome side effects to your doctor immediately. Dizziness may occur; refrain from operating machinery or driving until the drug's impact is understood. Prior to treatment, disclose any cardiac history. Pregnant or lactating individuals require medical consultation before commencing treatment. Comprehensive disclosure of all concurrent medications, particularly those for hypertension or heart disease, is crucial.
Uses of Nimomeg 10mg Infusion
Bleeding into the subarachnoid space
Major Benefits of Nimomeg 10mg Infusion:
This medication will be administered by your physician or their designated nurse. Self-medication is strongly discouraged.
Common Side effects of Nimomeg 10mg Infusion:
- Rash
- Headache
- Stomach discomfort
- Nausea
- Decreased blood pressure
- Slow heart rate
How to use Nimomeg 10mg Infusion:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Nimomeg 10mg Infusion works:
Cerebrovascular spasms are eased by Nimomeg 10mg Infusion, a calcium channel antagonist. Its action dilates constricted cerebral blood vessels, facilitating improved blood flow and mitigating brain injury following intracranial hemorrhage.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Nimomeg 10mg Infusion and alcohol can result in heightened sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Nimomeg 10mg Infusion during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Lactation and the administration of 10mg Nimomeg infusions likely pose minimal risk. Available human data indicates negligible infant harm.
DrivingUNSAFE
Administering Nimomeg 10mg Infusion may induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
The use of Nimomeg 10mg Infusion in patients with kidney impairment appears to pose minimal risk. Preliminary findings indicate dose modification may be unnecessary for this patient group. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data on Nimomeg 10mg Infusion use in patients with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Nimomeg 10mg Infusion :
NA
Facts to Know About Nimomeg 10mg Infusion
| Label | Value |
|---|---|
| Chemical Category | Dihydropyridine carboxylic acid derivatives |
| Developing Habits | No. |
| Type of Therapy | Heart |
| Actions | Dihydropyridine Calcium Channel Blockers |
3,018 People bought this recently